Form 4 Filing for IMMUNIC, INC. - Whaley Glenn

Glenn Whaley, Chief Financial Officer of IMMUNIC, INC., was granted 120,000 stock options on June 29, 2026. These options are subject to stockholder approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, which was obtained at the 2026 Annual Meeting of Stockholders. The options have an exercise price of $11.60 per share and an expiration date of April 2, 2036. The underlying shares are Common Stock. The options vest incrementally over a period of 37 months, starting with 25% on April 2, 2027.